Week in Review
Clovis Oncology Inc. set terms for its proposed $130.2 million initial public offering.
Dynavax Technologies Corp. raised $60 million in a public stock offering.
Human Genome Sciences Inc. priced a public offering of $494.5 million in convertible senior notes.
Karyopharm Therapeutics Inc. completed a $10 million Series A2 financing.
Verastem Inc. filed to raise $50 million in an initial public offering.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter